TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
虞凱傑Yu, Kai-Jie
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
-
m7398@cgmh.org.tw
發表文獻
7筆
1
Shao, I. H., Kan, H. C., Liu, C. Y., Lin, P. H., Yu, K. J., Pang, S. T., Wu, C. T., Chuang, C. K., Chang, Y. H. Role of Robot-Assisted Partial Nephrectomy For Renal Cell Carcinomas In The Purpose Of Nephron Sparing. Onco Targets Ther, 2019(12): 8189-8196.
2
Tseng, J. R., Yu, K. J., Liu, F. Y., Yang, L. Y., Hong, J. H., Yen, T. C., Pang, S. T., Wang, L. J. Comparison between (68)Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy. J Formos Med Assoc, 2020, 120(1 Pt 3): 688-696
3
Li, Y. R., Yu, K. J., Chang, Y. H., Lin, P. H., Shao, I. H., Kan, H. C., Chu, Y. C., Chuang, C. K., Pang, S. T., Liu, C. Y. Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma. Cancer Manag Res, 2020(12): 7439-7450.
4
Lin, P. H., Chang, S. W., Tsai, L. H., Kan, H. C., Liu, J. M., Chuang, C. K., Pang, S. T., Yu, K. J. Increasing incidence of prostate cancer in Taiwan: A study of related factors using a nationwide health and welfare database. Medicine (Baltimore), 2020, 99(39): e22336
5
Weng, W. H., Yu, K. J., Li, L. C., Pang, Y. J., Chen, Y. T., Pang, S. T., Chuang, C. K. Low PTEN expression and overexpression of phosphorylated Akt(Ser473) and Akt(Thr308) are associated with poor overall survival in upper tract urothelial carcinoma. Oncol Lett, 2020, 20(6): 347.
6
Lin, P. H., Huang, C. Y., Yu, K. J., Kan, H. C., Liu, C. Y., Chuang, C. K., Lu, Y. C., Chang, Y. H., Shao, I. H., Pang, S. T. Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing. Oncol Lett, 2021, 21(2): 169.
7
Su, S. H., Chang, Y. H., Huang, L. K., Chu, Y. C., Kan, H. C., Liu, C. Y., Lin, P. H., Yu, K. J., Wu, C. T., Pang, S. T., Chuang, C. K., Shao, I. H. Clinical predictors for biochemical failure in patients with positive surgical margin after robotic-assisted radical prostatectomy. Tumori, 2021: 3008916211007928
